Epidemiology of Adverse Effects following COVID-19 Vaccination among Subjects visiting Tikrit Teaching Hospital Outpatients Clinics.

Autor: hussen, Ehan abdlhadi, Al-khalidi, Zeena N. A., Saeed, Hussam D.
Předmět:
Zdroj: Medical Journal of Tikrit; 2022, Vol. 28 Issue 2, p63-72, 10p
Abstrakt: Back ground: Coronavirus disease 2019 (COVID-19) was first identified in China leading to out break of respiratory illness. there are many vaccination used for prevention of the disease. Many side effects appeared with taking theses vaccine as pain, redness, swelling at site of injection and systemic effects (e.g, fever, fatigue, headache, muscle or joint pain, with rare serious adverse events. Patients and methods: The current study was descriptive one, it was conducted among persons vaccinated with Covid-19 vaccines from the period 14th November 2021-18th march 2022 in Tikrit city. The sample was taken from people attending Tikrit teaching hospital out patient clinics and those previously taken the vaccines. The information was obtained according to a designed questionnaire which included all information regarding certain demographic characteristics and common adverse effects as a result of COVID-19 vaccination according to vaccine type. Results: The most frequent adverse effects was among subjects given AstraZeneca vaccine, followed among those given Pfizer vaccine and the last among those given Sinopharm vaccine. The more frequent cases with adverse effect with AstraZeneca and Pfizer vaccine was among age group (35-45 years) (63%,70.2% respectively) while those among those given Sinopharm was among age group less than 35 years (38.2%).The commonest adverse effect of COVID-19 vaccination was pain/tenderness at site of injection (76.3%) followed by fever/chills (70.6%) and muscle weakness/tiredness (66.6%). Conclusion: The most frequent adverse effects of COVID-19 vaccination was pain/tenderness at site of injection and the highest frequency of adverse effects were among those given AstraZeneca vaccine. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index